143 related articles for article (PubMed ID: 21495260)
21. Effect of Stereochemical Configuration on the Transport and Metabolism of Catechins from Green Tea across Caco-2 Monolayers.
Ai Z; Liu S; Qu F; Zhang H; Chen Y; Ni D
Molecules; 2019 Mar; 24(6):. PubMed ID: 30917581
[TBL] [Abstract][Full Text] [Related]
22. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
Guo A; Marinaro W; Hu P; Sinko PJ
Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
[TBL] [Abstract][Full Text] [Related]
23. Transepithelial transport mechanisms of 7,8-dihydroxyflavone, a small molecular TrkB receptor agonist, in human intestinal Caco-2 cells.
Chen Y; Xue F; Xia G; Zhao Z; Chen C; Li Y; Zhang Y
Food Funct; 2019 Aug; 10(8):5215-5227. PubMed ID: 31384856
[TBL] [Abstract][Full Text] [Related]
24. Long-chain acylcarnitines mediate the hypoxia-induced increase in alpha 1-adrenergic receptors on adult canine myocytes.
Heathers GP; Yamada KA; Kanter EM; Corr PB
Circ Res; 1987 Nov; 61(5):735-46. PubMed ID: 2822280
[TBL] [Abstract][Full Text] [Related]
25. Effects of capsaicin on cellular damage and monolayer permeability in human intestinal Caco-2 cells.
Tsukura Y; Mori M; Hirotani Y; Ikeda K; Amano F; Kato R; Ijiri Y; Tanaka K
Biol Pharm Bull; 2007 Oct; 30(10):1982-6. PubMed ID: 17917278
[TBL] [Abstract][Full Text] [Related]
26. Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 in Caco-2 cells.
Zhu X; Zhang X; Ma G; Yan J; Wang H; Yang Q
J Pharm Pharm Sci; 2011; 14(3):325-35. PubMed ID: 21824448
[TBL] [Abstract][Full Text] [Related]
27. Contribution of cholesterol and phospholipids to inhibitory effect of dimethyl-beta-cyclodextrin on efflux function of P-glycoprotein and multidrug resistance-associated protein 2 in vinblastine-resistant Caco-2 cell monolayers.
Arima H; Yunomae K; Morikawa T; Hirayama F; Uekama K
Pharm Res; 2004 Apr; 21(4):625-34. PubMed ID: 15139519
[TBL] [Abstract][Full Text] [Related]
28. Interplay between CYP3A-mediated metabolism and polarized efflux of terfenadine and its metabolites in intestinal epithelial Caco-2 (TC7) cell monolayers.
Raeissi SD; Hidalgo IJ; Segura-Aguilar J; Artursson P
Pharm Res; 1999 May; 16(5):625-32. PubMed ID: 10350002
[TBL] [Abstract][Full Text] [Related]
29. Validation and application of Caco-2 assays for the in vitro evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions.
Elsby R; Surry DD; Smith VN; Gray AJ
Xenobiotica; 2008 Jul; 38(7-8):1140-64. PubMed ID: 18668443
[TBL] [Abstract][Full Text] [Related]
30. Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers?
Behrens I; Kissel T
Eur J Pharm Sci; 2003 Aug; 19(5):433-42. PubMed ID: 12907294
[TBL] [Abstract][Full Text] [Related]
31. Involvement of cholesterol in the inhibitory effect of dimethyl-beta-cyclodextrin on P-glycoprotein and MRP2 function in Caco-2 cells.
Yunomae K; Arima H; Hirayama F; Uekama K
FEBS Lett; 2003 Feb; 536(1-3):225-31. PubMed ID: 12586368
[TBL] [Abstract][Full Text] [Related]
32. Chitosan-N-acetyl cysteine conjugates: in vitro evaluation of permeation enhancing and P-glycoprotein inhibiting properties.
Schmitz T; Hombach J; Bernkop-Schnürch A
Drug Deliv; 2008 May; 15(4):245-52. PubMed ID: 18446570
[TBL] [Abstract][Full Text] [Related]
33. Characterization and Validation of Canine P-Glycoprotein-Deficient MDCK II Cell Lines for Efflux Substrate Screening.
Ye D; Harder A; Fang Z; Weinheimer M; Laplanche L; Mezler M
Pharm Res; 2020 Sep; 37(10):194. PubMed ID: 32918191
[TBL] [Abstract][Full Text] [Related]
34. Effect of HEPES buffer on the uptake and transport of P-glycoprotein substrates and large neutral amino acids.
Luo S; Pal D; Shah SJ; Kwatra D; Paturi KD; Mitra AK
Mol Pharm; 2010 Apr; 7(2):412-20. PubMed ID: 20163160
[TBL] [Abstract][Full Text] [Related]
35. Effects of L-carnitine on action potential or canine papillary muscle impaired by long chain acyl carnitine.
Hayashi H; Suzuki Y; Masumura Y; Kamikawa T; Kobayashi A; Yamazaki N
Jpn Heart J; 1982 Jul; 23(4):623-30. PubMed ID: 7131787
[TBL] [Abstract][Full Text] [Related]
36. Potential roles of P-gp and calcium channels in loperamide and diphenoxylate transport.
Crowe A; Wong P
Toxicol Appl Pharmacol; 2003 Nov; 193(1):127-37. PubMed ID: 14613723
[TBL] [Abstract][Full Text] [Related]
37. Carrier mechanisms involved in the transepithelial transport of bis(POM)-PMEA and its metabolites across Caco-2 monolayers.
Annaert P; Van Gelder J; Naesens L; De Clercq E; Van den Mooter G; Kinget R; Augustijns P
Pharm Res; 1998 Aug; 15(8):1168-73. PubMed ID: 9706045
[TBL] [Abstract][Full Text] [Related]
38. Molecular weight-dependent paracellular transport of fluorescent model compounds induced by palmitoylcarnitine chloride across the human intestinal epithelial cell line Caco-2.
Chao AC; Taylor MT; Daddona PE; Broughall M; Fix JA
J Drug Target; 1998; 6(1):37-43. PubMed ID: 9769019
[TBL] [Abstract][Full Text] [Related]
39. Effects of Acanthopanax senticosus HARMS extract on drug transport in human intestinal cell line Caco-2.
Takahashi T; Kaku T; Sato T; Watanabe K; Sato J
J Nat Med; 2010 Jan; 64(1):55-62. PubMed ID: 20091240
[TBL] [Abstract][Full Text] [Related]
40. In vitro interactions between aged garlic extract and drugs used for the treatment of cardiovascular and diabetic patients.
Berginc K; Žakelj S; Kristl A
Eur J Nutr; 2010 Sep; 49(6):373-84. PubMed ID: 20140680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
